Title | The Kidney and Hypertension in Diabetes Mellitus [electronic resource] / edited by Carl Erik Mogensen |
---|---|
Imprint | Boston, MA : Springer US : Imprint: Springer, 2000 |
Edition | Fifth Edition |
Connect to | http://dx.doi.org/10.1007/978-1-4615-4499-9 |
Descript | XXXVIII, 722 p. online resource |
1. Pressure induced and metabolic alterations in the glomerulus: Role in cytokine activity and progressive sclerosis -- 2. Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests -- 3. Retinopathy in relation to albuminuria and blood pressure in IDDM -- 4. Microalbuminuria and cardiovascular disease -- 5. The heart in diabetes: results of trials -- 6. Albuminuria in non-insulin-dependent diabetes โ renal or โextraโ renal disease? -- 7. The clinical course of renal disease in Caucasian NIDDM-patients -- 8. Serum creatinine and other measures of GFR in diabetes -- 9. Familial factors in diabetic nephropathy -- 10. Genetics and diabetic nephropathy -- 11. Birth, Barker and Brenner: The concept of low birth weight and renal disease -- 12. Effect of insulin on the kidney and the cardiovascular system -- 13 Value of screening for microalbuminuria in people with diabetes as well as in the general population -- 14. Incidence of nephropathy in IDDM as related to mortality. Cost and benefits of early intervention. -- 15. Dysfunction of the vascular endothelium and the development of renal and vascular complications in diabetes -- 16. Urinary tract infections in patients with diabetes mellitus -- 17. Light microscopy of diabetic glomerulopathy: the classic lesions -- 18. Renal structural changes in patients with type 1 diabetes and microalbuminuria -- 19. Renal structure in type 2 diabetic patients with microalbuminuria -- 20. Nephropathy in NIDDM patients, predictors of outcome -- 21. Advanced glycation end-products and diabetic renal disease -- 22. Protein kinase C in diabetic renal involvement, the perspective of inhibition -- 23. Biochemical aspects of diabetic nephropathy -- 24. Pathogenesis of diabetic glomerulopathy: the role of glomerular hemodynamic factors -- 25. An update on the role of growth factors in the development of diabetic kidney disease -- 26. Transforming growth factor-? and other cytokines in experimental and human diabetic nephropathy -- 27. Blood pressure elevation in diabetes: the results from 24-h ambulatory blood pressure recordings -- 28. Microalbuminuria in young patients with type 1 diabetes -- 29. Early renal hyperfunction and hypertrophy in IDDM patients including comments on early intervention -- 30. Diabetes, hypertension, and kidney disease in the Pima Indians -- 31. Autoregulation of glomerular filtration rate in patients with diabetes -- 32. ACE-inhibition, angiotensin II receptor blockade, and diabetic nephropathy -- 33. The concept of incipient diabetic nephropathy and effect of early antihypertensive intervention -- 34. Reversibility of diabetic nephropathy lesions: A new concept -- 35. Antihypertensive treatment in NIDDM, with special reference to abnormal albuminuria. -- 36. The course of incipient and overt diabetic nephropathy: the perspective of more optimal treatment, including UKPDS-perspective -- 37. Non-glycaemic intervention in diabetic nephropathy: the role of dietary protein intake -- 38. Diabetic nephropathy and pregnancy -- 39. Evolution worldwide of renal replacement therapy in diabetes -- 40. Haemodialysis and CAPD in type 1 and type 2 diabetic patients with endstage renal failure -- 41. Renal transplantation for diabetic nephropathy -- 42. Combination therapy for hypertension and renal disease in diabetes -- 43. Microalbuminuria in essential hypertension. Significance for the cardiovascular and renal systems -- 44. A comparison of progression in diabetic and non-diabetic renal disease: similarity of progression promoters -- 45. Update of the latest intervention trials in hypertension and type 2 diabetes -- 46. Scientific basis for the new guidelines for the treatment of hypertension in type 2 diabetes -- 47. Regulatory considerations in the development of therapies for diabetic nephropathy and related conditions -- 48. The renin angiotensin system in the pathogenesis of diabetic complications -- 49. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas